Richard N Harkins

Title: Innovations and Contributions of Richard N Harkins

Introduction

Richard N Harkins is a notable inventor based in Alameda, CA, with a significant portfolio of nine patents. His work primarily focuses on biotechnological advancements, particularly in the production of recombinant proteins and novel human antibodies.

Latest Patents

Among his latest patents, Harkins has developed methods and compositions for the production of recombinant proteins in HBX-expressing mammalian cells. This method allows for the effective production of heterologous proteins in various mammalian host cells, including HKB11, CHO, BHK21, C2C12, and HEK293 cells. The invention emphasizes the importance of specific growth conditions to ensure the expression of HBx, exogenous XBP1s, and the heterologous protein. Additionally, he has patented isolated human antibodies that bind to epitopes on RG1. This invention encompasses novel human extracellular matrix polypeptides, methods for their production, and applications in research, diagnosis, and therapeutic fields.

Career Highlights

Harkins has had a distinguished career, contributing to significant advancements in biotechnology. He has worked with prominent companies such as Bayer Schering Pharma AG and Schering Aktiengesellschaft, where he has applied his expertise in developing innovative solutions in the field.

Collaborations

Throughout his career, Harkins has collaborated with notable colleagues, including Deborah Parkes and Gordon Parry. These collaborations have further enhanced his contributions to the field of biotechnology.

Conclusion

Richard N Harkins stands out as a prominent inventor whose work has significantly impacted the biotechnology sector. His innovative patents and collaborations reflect his dedication to advancing scientific knowledge and applications.